Abstract
Purpose of the study: Therapeutic hypothermia (TH) improves neurological outcome after cardiac arrest (CA) but may yield an increased risk of infection.1,2 Davies et al.3 reported increased survival when patients treated with TH after out-of-hospital CA were given early systemic antibiotics when compared to those patients who received late antibiotics. The reported ventilator associated pneumonia (VAP) rate in the literature, in non-TH patients, ranges from 9% to 27%.4 The VAP rate in TTM trial5 was 21.22% both for normothermic and hypothermic patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
